NCT06794775
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06794775
Title SWE-NEO: Swedish NeoAdjuvant Trial Comparing Monotherapy to Combined Immunotherapy in Resectable Stage III Melanoma (SWE-NEO)
Acronym SWE-NEO
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Hildur Helgadottir
Indications
Therapies
Age Groups: adult | senior
Covered Countries SWE

Facility Status City State Zip Country Details
Sahlgrenska University Hospital RECRUITING Gothenburg Sweden Details
Skane University Hospital RECRUITING Lund Sweden Details
Karolinska University Hospital RECRUITING Stockholm Sweden Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field